Litcius/Paper detail

Melittin Treats Periprosthetic Osteolysis in a Rat Model by Inhibiting the NF-kB Pathway and Regulating the Ratio of Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin

J. Niu, Fanggang Bi, Qing Tian, Ke Tian

2024The Journal of Arthroplasty10 citationsDOI

Topics & Concepts

OsteoprotegerinActivator (genetics)OsteolysisRANKLNF-κBNFKB1Cancer researchReceptorChemistryInternal medicineMedicineCell biologyEndocrinologyTranscription factorBiologyInflammationBiochemistryDentistryGeneHealthcare and Venom ResearchBeetle Biology and Toxicology StudiesBee Products Chemical Analysis
Melittin Treats Periprosthetic Osteolysis in a Rat Model by Inhibiting the NF-kB Pathway and Regulating the Ratio of Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin | Litcius